Embody vs. Enhance.MD: prices, fine print, and the honest verdict

Tirzepatide pricing

Embody carries only a reported figure — $99/mo from a competing comparison site (May 2026), never captured on a provider page — so it is listed, reviewed, and excluded from ranked comparisons pending verification. Enhance.MD does not offer tirzepatide.

Semaglutide pricing

Only Enhance.MD publishes a semaglutide price here: Semaglutide runs $249 a month all-in at the standing rate ($212 on intro/plan terms). Embody doesn't sell compounded semaglutide.

Transparency

Embody: Third-party-reported; dispensing pharmacy not publicly named. Enhance.MD: Source-verified (verified 2026-08-08); dispensing pharmacy not publicly named. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Embody: terms not published. Enhance.MD: none month-to-month; term plans paid per schedule.

The semaglutide board

Only Enhance.MD fields a verified semaglutide price here — $249/month all-in (#12 of 19) — while Embody publishes no semaglutide figure we could capture. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Embody's reported $99 can't be normalized because no source page confirms what it includes; Enhance.MD publishes no figure to normalize. 4 · Evidence tiered. Embody: third-party-reported; Enhance.MD: source-verified, read 2026-08-08. 5 · Pharmacy weighed. Embody names no pharmacy; Enhance.MD names no pharmacy — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Embody: no membership — the medication figure is the billed figure. Enhance.MD: no membership — the medication figure is the billed figure; prepaid 12-month plan at $212/mo effective; term plans paid per schedule; commitment: none month-to-month. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Embody carries third-party-reported pricing; its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Enhance.MD carries source-verified pricing (last read 2026-08-08); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Moving from Embody to Enhance.MD (or back) is administratively unglamorous: complete the new program's intake, let its prescriber issue a fresh prescription to its pharmacy, and cancel the old subscription in writing — prescriptions don't transfer between telehealth programs, and neither do prepaid balances, which is the quiet reason month-to-month terms are worth their premium.

Refills, shipping, and the week-to-week reality

The unglamorous layer — how the medication actually reaches you and stays on schedule — splits like this: Embody: shipping, consult, and refill logistics aren’t published in our capture — ask at intake, in writing. Enhance.MD: shipping included; consultation included; async visit model. Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Embody if its published terms happen to fit your state, format, or timing. Pick Enhance.MD if you'll prepay for the $212 effective rate. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

What verification would take

For Embody, ranking would require: a provider-page capture confirming the reported $99 figure and exactly what it includes; the dose structure (flat or scaled, with the 10 mg tier stated); the pharmacy's name, 503A/503B status, and state licensure; commitment and cancellation terms verbatim. We publish the checklist because the gap is fixable — providers that clear it get ranked on the same arithmetic as everyone else, and readers who ask these questions get the answers this page can't yet print.

If neither one fits

The dataset's bench is deep; the closest verified third options to this matchup's price band are NexLife at $215 (flat, no membership, named pharmacy); Yucca Health at $258 (flat, no membership); IVIM Health at $278 (dose-scaled, $75 membership included) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

With incomplete published pricing on one or both sides, get current figures in writing before enrolling with either. Both records, with dates and sources, live in the pricing database.